GMED250117P95000
- 11.80
- 0.000.00%
Globus Medical Newsroom
Globus Medical Insider Sold Shares Worth $1,250,770, According to a Recent SEC Filing
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $100 to $115
Globus Medical Is Maintained at Buy by Canaccord Genuity
GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $90 to $115
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Reviva Pharmaceuticals Holdings (RVPH)
Globus Medical Insider Lowered Holding By 100% During Last Year
Express News | Globus Medical Inc : BofA Global Research Raises Price Objective to $97 From $80
Globus Medical Upgraded to Neutral From Underperform at BofA
Globus Medical Analyst Ratings
Needham Maintains Globus Medical(GMED.US) With Hold Rating
Needham Keeps Their Hold Rating on Globus Medical (GMED)
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $95
Positive Outlook and Buy Rating for Globus Medical Amid Strong Sales and Market Confidence
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
BTIG Sticks to Their Buy Rating for Globus Medical (GMED)
Globus Medical Reports Preliminary Q4 Sales $657M, Up 6.6% YoY; FY24 Sales $2.52B, Up 60.6% YoY; Sees 2025 Revenue $2.66B-$2.69B Vs $2.67B Est.; Non-GAAP EPS $3.40-$3.50 Vs $3.42 Est.
Globus Medical Sees 2025 Adj EPS $3.40-Adj EPS $3.50 >GMED
Express News | Globus Medical Inc - Outlook FY 2025 Revenue Guidance at $2.66-$2.69 Billion